 Cantourage Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than
Ananda Developments Aquis-listed pharmaceutical cannabis company Ananda Developments welcomed two new scientific advisors ‘to assist the company in developing
As reported by Cannareporter. Avextra will move forward with a double-blind Phase 2 clinical trial for the use of cannabis in
Cantourage This week Cantourage UK, a subsidiary of the German-listed cannabis distribution group, signed a supply agreement which will
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
